DE539163C - Process for the production of an ergot preparation from which dietary fiber has been removed from mixtures obtained by extracting ergot with organic solvents - Google Patents

Process for the production of an ergot preparation from which dietary fiber has been removed from mixtures obtained by extracting ergot with organic solvents

Info

Publication number
DE539163C
DE539163C DEG63787D DEG0063787D DE539163C DE 539163 C DE539163 C DE 539163C DE G63787 D DEG63787 D DE G63787D DE G0063787 D DEG0063787 D DE G0063787D DE 539163 C DE539163 C DE 539163C
Authority
DE
Germany
Prior art keywords
ergot
production
dietary fiber
extracting
organic solvents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DEG63787D
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gehe & Co Akt Ges
Original Assignee
Gehe & Co Akt Ges
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gehe & Co Akt Ges filed Critical Gehe & Co Akt Ges
Priority to DEG63787D priority Critical patent/DE539163C/en
Application granted granted Critical
Publication of DE539163C publication Critical patent/DE539163C/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/066Clavicipitaceae
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/183Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing an indolo[4,3-F,G]quinoleine nucleus, e.g. compound containing the lysergic acid nucleus as well as the dimeric ergot nucleus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

Verfahren zur Herstellung eines von Ballaststoffen gereinigten Mutterkornpräparates aus durch Extraktion von Mutterktrn mit organischen Lösungsmitteln erhaltenen Gemischen Die Zahl der im Mutterkorn (Claviceps purpurea [Fries] Tulasne) aufgefundenen Bestandteile ist sehr groß. Man kann mit T s c h i r c h sagen: »Jeder Autor fand etwas anderes als seine Vorgänger«. Es ist darauf zurückzuführen, daß die Inhaltsstoffe der Droge gegen eine Behandlung mit chemischen Mitteln oder gegen die Methoden der Extraktbereitung sehr empfindlich sind und dabei eine teilweise Zersetzung erleiden. Daher ist ein großer Teil der in der Literatur angegebenen Bestandteile des Mutterkorns in dieser Droge nicht vorgebildet.Process for the production of an ergot preparation that has been purified from dietary fiber from mixtures obtained by extraction of mother wort with organic solvents The number of components found in ergot (Claviceps purpurea [Fries] Tulasne) is very big. You can say with T s c h i r c h: »Every author found something different than his predecessors «. It is due to the ingredients of the drug against treatment with chemical agents or against the methods of extract preparation are very sensitive and suffer partial decomposition in the process. Hence a large part of the components of ergot indicated in the literature in this one Drug not preformed.

Es kommt darauf an, die Droge der schonendsten Behandlung zu unterziehen, um ihre genuinen Inhaltsstoffe zu isolieren. Gegenstand der vorliegenden Erfindung ist ein Verfahren, die Isolierung unter größtmöglicher Schonung der Droge und ihrer wertvollen Bestandteile vorzunehmen. Es werden daher, solange die Droge verarbeitet wird, keine stark wirkenden Chemikalien, wie Säuren, saure Salze, noch Alkalien oder Erdalkalien angewandt. Ebenso wird ein Ausziehen der Droge unter Erwärmen vermieden. Auf diese Weise ist die Sicherheit gewahrt, daß die Natur der in der Droge enthaltenen wirksamen Bestandteile keine nachteilige Veränderung erfährt.It is important to subject the drug to the gentlest possible treatment, to isolate their genuine ingredients. Subject of the present invention is a process that isolates the drug and it with the greatest possible care make valuable components. It will therefore be processed as long as the drug is used no strong chemicals such as acids, acidic salts, nor alkalis or alkaline earths applied. Likewise, taking off the drug while warming is avoided. In this way you can be sure of the nature of the substances contained in the drug active ingredients does not experience any adverse change.

Das vorliegende Verfahren arbeitet so, daß es die meistens fein gepulverte Dröge der Extraktion mit Äther oder anderen organischen Lösungsmitteln (Benzol und Homologe, chlorierte Kohlenwasserstoffe u. a.) in der Kälte unterwirft und den nach Abtrennen der ätherischen Lösung und Verjagen des Äthers .erhaltenen Anteil mit organisch saurem Äther mischt, worauf ein Niederschlag entsteht, der nach den allgemeinen Methoden der Alkaloidchemie weitergereinigt wird.The present process works so that it is mostly finely powdered Dröge of extraction with ether or other organic solvents (benzene and Homologous, chlorinated hydrocarbons, etc.) in the cold and the after Separating the ethereal solution and driving away the ether organically acidic ether mixes, whereupon a precipitate arises, which according to the general Methods of alkaloid chemistry is further purified.

Das Patent 226 469 behandelt ein Verfahren zur Herstellung eines Präparates aus Mutterkorn, das die Droge nicht unmittelbar zu Auszügen ihrer therapeutisch wichtigen Bestandteile heranzieht, sondern das Mutterkorn zunächst entfettet und nach der Entfernung des Fettes dieses beseitigt, die wirksamen Bestandteile aber der vorbehandelten Droge entzieht, indem es diese nicht wie früher erst mit Wasser und danach mit Alkohol in Lösung bringt. Hiervon unterscheidet sich unser Verfahren dadurch, daß es unmittelbar von der ölhaltigen Droge ausgeht und den öligen Auszug selbst zur schonenden Gewinnung der Basenbestandteile einem ausführlichen Reinigungsverfahren nach den Methoden der Alkaloidchemie unterwirft.Patent 226,469 deals with a method of making a preparation from ergot, which the drug does not directly extract its therapeutic from important components, but the ergot first degreased and After the fat has been removed, it is eliminated, but the active components withdraws from the pretreated drug by not adding water to it, as was previously the case and then brings it into solution with alcohol. Our procedure differs from this in that it proceeds directly from the oil-containing drug and the oily extract an extensive cleaning process even for the gentle extraction of the base components subject to the methods of alkaloid chemistry.

Die Lösungen der Basen mit Säuren oder ihre Salze selbst sollen therapeutische Anwendung finden. Beispiel 5 kg Mutterkorn werden fein gemahlen und mit Äther restlos extrahiert. Der vom Lösungsmittel befreite klare Ölrückstand wird nun mit möglichst trockenem, mit Zitronensäure gesättigtem Äther unter ständigem Umrühren versetzt; es scheidet sich sofort ein gelblicher, flockiger Niederschlag aus, der abgesaugt und gut nachgewaschen über Kalk getrocknet wird. Nun löst man den Rückstand unter Anreiben mit io °/o Essigsäure, schüttelt mit Äther die Ballaststoffe mehrmals aus, filtriert die saure Lösung blank und fällt unter ständigem Umrühren das Alkaloidgemisch mit Ammoniak aus. Der Niederschlag wird abgesaugt und wieder über Kalk getrocknet. Aus dem trocknen grauweißen Pulver wird auf die übliche Weise das weinsaure Salzgemisch hergestellt. Der Stickstoffgehalt des Basengemisches beträgt im Durchschnitt 9,5 bis io,5 °i(,. Eine Probe mit Eisessig, der i °/a Ferrisulfatlösung i : ioo enthält, gelöst, gibt beim Unterschichten mit konzentrierter Schwefelsäure sofort eine kornblumenblaue Zone an der Berührungsfläche. Das Salzgemisch stellt ein weißliches P--lver dar, das in Wasser gut löslich ist.The solutions of the bases with acids or their salts themselves are said to be therapeutic Find application. Example 5 kg of ergot are finely ground and completely removed with ether extracted. The clear oil residue freed from the solvent is now with as possible dry, with citric acid saturated ether under constant Stirring added; a yellowish, flaky precipitate separates out immediately which is vacuumed off and washed well over lime, dried. Now you solve rub the residue with 10% acetic acid, shake the fiber with ether several times, the acidic solution filtered off and falls with constant stirring the alkaloid mixture with ammonia. The precipitate is sucked off and again dried over lime. The dry off-white powder becomes in the usual way the tartaric salt mixture produced. The nitrogen content of the base mixture is an average of 9.5 to 10.5%. A sample with glacial acetic acid, the 1% ferric sulfate solution i: ioo contains, dissolved, gives when underlaying with concentrated sulfuric acid immediately a cornflower blue zone on the contact surface. The salt mixture represents is a whitish powder that is readily soluble in water.

Claims (1)

PATENTANSPRUCH: Verfahren zur Herstellung eines von Ballaststoffen gereinigten Mutterkornpräparates aus durch Extraktion von Mutterkorn mit organischen Lösungsmitteln erhaltenen Gemischen, dadurch gekennzeichnet, daß der nach Verjagen des Extraktionsmittels verbleibende Rückstand unmittelbar mit organische Säuren enthaltendem Äther behandelt und der dabei sich abscheidende, die Alkaloidsalze enthaltende Niederschlag nach bekannten Verfahren der Alkaloidchemie aufgearbeitet wird.PATENT CLAIM: Process for the production of a dietary fiber Purified ergot preparation made by extracting ergot with organic Mixtures obtained from solvents, characterized in that the after expulsion of the extractant remaining residue immediately with organic acids containing ether treated and the thereby deposited, the alkaloid salts containing precipitate worked up by known methods of alkaloid chemistry will.
DEG63787D 1925-03-19 1925-03-19 Process for the production of an ergot preparation from which dietary fiber has been removed from mixtures obtained by extracting ergot with organic solvents Expired DE539163C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DEG63787D DE539163C (en) 1925-03-19 1925-03-19 Process for the production of an ergot preparation from which dietary fiber has been removed from mixtures obtained by extracting ergot with organic solvents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEG63787D DE539163C (en) 1925-03-19 1925-03-19 Process for the production of an ergot preparation from which dietary fiber has been removed from mixtures obtained by extracting ergot with organic solvents

Publications (1)

Publication Number Publication Date
DE539163C true DE539163C (en) 1931-11-24

Family

ID=7133323

Family Applications (1)

Application Number Title Priority Date Filing Date
DEG63787D Expired DE539163C (en) 1925-03-19 1925-03-19 Process for the production of an ergot preparation from which dietary fiber has been removed from mixtures obtained by extracting ergot with organic solvents

Country Status (1)

Country Link
DE (1) DE539163C (en)

Similar Documents

Publication Publication Date Title
DE539163C (en) Process for the production of an ergot preparation from which dietary fiber has been removed from mixtures obtained by extracting ergot with organic solvents
AT117679B (en) Process for obtaining the active bases of ergot.
DE830195C (en) Process for the production of highly effective ergot alkaloid extracts
DE966726C (en) Process for the enrichment of the active ingredients of Rauwolfia species
DE696390C (en) Process for enriching the antipernicious agent
DE326081C (en) Process for the preparation of a water-soluble, injectable extract of the total alkaloids of opium
CH121927A (en) Process for the preparation of an ergot preparation that has been purified from dietary fiber.
DE701956C (en) Process for obtaining hormone-like substances
DE406150C (en) Process for the extraction of phenols from tars or tea oils of all kinds
DE633377C (en) Process for the production of diuresis-promoting and diure-inhibiting substances
DE668473C (en) Process for the gentle extraction of extractive substances from body juice
DE367538C (en) Process for the production of pure acetonitrile
DE563258C (en) Process for the preparation of water-soluble, hormone-like, growth-promoting substances from thymus glands
DE950674C (en) Process for obtaining active substances from aqueous extracts of Echinacea species
DE565065C (en) Process for the separate recovery of a hypertensive substance and a uterine muscle contracting substance from the posterior lobe of the pituitary gland
DE435530C (en) Process for obtaining a therapeutically active substance
DE693299C (en) Process for the manufacture of a medicament
DE852120C (en) Method of obtaining a medicinal product
DE614702C (en) Process for separating fatty acid esters from sulfonation mixtures
DE468810C (en) Process for the manufacture of a hormone-containing substance of plant origin
DE464614C (en) Process for the preparation of an injection agent against tuberculosis
DE559143C (en) Process for the separate recovery of posterior pituitary lobe hormone and anterior pituitary lobe hormone
DE263354C (en)
DE383480C (en) Process for the preparation of a highly concentrated dry digital extract containing the total glycosides of the digitalis leaves
DE613262C (en) Process for the extraction and separation of the physiological substances influencing the calcium metabolism